Compare OVID & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OVID | CHMI |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | United States | United States |
| Employees | N/A | 14 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.5M | 98.5M |
| IPO Year | 2017 | N/A |
| Metric | OVID | CHMI |
|---|---|---|
| Price | $2.51 | $2.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $4.20 | $3.00 |
| AVG Volume (30 Days) | ★ 3.1M | 174.3K |
| Earning Date | 03-18-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 14.71% |
| EPS Growth | ★ 3.90 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,252,000.00 | N/A |
| Revenue This Year | $1,077.56 | N/A |
| Revenue Next Year | N/A | $59.20 |
| P/E Ratio | ★ N/A | $139.30 |
| Revenue Growth | ★ 1181.27 | N/A |
| 52 Week Low | $0.24 | $2.17 |
| 52 Week High | $2.72 | $3.66 |
| Indicator | OVID | CHMI |
|---|---|---|
| Relative Strength Index (RSI) | 76.72 | 60.23 |
| Support Level | $1.31 | $2.52 |
| Resistance Level | N/A | $2.76 |
| Average True Range (ATR) | 0.21 | 0.07 |
| MACD | 0.07 | 0.01 |
| Stochastic Oscillator | 82.11 | 97.30 |
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Cherry Hill Mortgage Investment Corp is a fully integrated, internally managed residential real estate finance company focused on acquiring, investing in and managing residential mortgage assets in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.